Stay updated on Long-term Esketamine Study in Depression: Clinical Trial
Sign up to get notified when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.

Latest updates to the Long-term Esketamine Study in Depression: Clinical Trial page
- Check3 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site revision as v3.8.1 instead of v3.8.0.SummaryDifference0.0%

- Check10 days agoChange DetectedThe record shows details of the completed Phase 3 SUSTAIN-2 study of intranasal esketamine for treatment-resistant depression, including its design, eligibility criteria, outcomes, locations, and publications.SummaryDifference92%

- Check17 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedA sitewide NIH banner announces a transition from “Artificial Intelligence” to “Super Intelligence” terminology. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check45 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1, while the page still displays a 403 error.SummaryDifference0.2%

- Check59 days agoChange DetectedAccess to the page is restricted, and a 403 Forbidden message is shown, replacing the prior study record details. This reads as an error state rather than a content update.SummaryDifference17%

Stay in the know with updates to Long-term Esketamine Study in Depression: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Esketamine Study in Depression: Clinical Trial page.